Vinay Prasad, a critic of the Food and Drug Administration, has been tapped as the agency’s top regulator of vaccines, gene therapies and the blood supply.

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...

Dr. Vinay Prasad, a vocal critic of the agency's moves to greenlight COVID-19 vaccine boosters. Prasad replaces Dr. Peter Marks, who served as the director of the Center for Biologics Evaluation ...

At the American Society of Cell and Gene Therapy conference, there were questions and qualms on how Vinay Prasad may change FDA policy.

Vinay Prasad has worked as a professor of medicine ... He steps into the shoes vacated by Peter Marks, who resigned from the role a few weeks ago – reportedly before being pushed out ...

WASHINGTON — Vinay Prasad, an academic and fierce critic ... Prasad replaces former CBER director Peter Marks, who was forced to resign by health secretary Robert F. Kennedy Jr. in March.

The Food and Drug Administration (FDA) has tapped Vinay Prasad ... to lead the agency’s vaccines division. Prasad replaces Peter Marks, the longtime leader of the Center for Biologics Evaluation ...

The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and COVID-19 mandates, as the director of its Center for Biologics Evaluation ...

Vinay Prasad, MD, MPH, a frequent critic of the ... Francisco (UCSF), who has not worked for the FDA before, replaces Peter Marks, MD, PhD, who was forced out of the position in March after ...

(Reuters) - The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized the FDA ...